VBI Vaccines to Present at the World Vaccine Congress Washington
29 mars 2016 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the World Vaccine Congress Washington on Wednesday, March 30th, 2016 at 12:10...
VBI Vaccines Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference
07 mars 2016 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., March 07, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) today will present new data supporting its glioblastoma multiforme (“Glioblastoma” or “GBM”) cancer...
VBI Vaccines to Present at the ROTH Conference
03 mars 2016 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., March 03, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the 28th Annual ROTH Conference on Tuesday, March 15th, 2016 at 5:30 PM PT...
VBI Vaccines Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability
09 févr. 2016 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Feb. 09, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) has entered into a research collaboration with GlaxoSmithKline Biologicals SA (“GSK”) to evaluate VBI’s...
VBI Vaccines Partners with the Canadian CMV Foundation to Raise Congenital Cytomegalovirus Awareness
04 févr. 2016 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is proud to announce its continued sponsorship support of Le Classique, the Canadian CMV Foundation’s...
VBI Vaccines to Present at the BIO CEO & Investor Conference
26 janv. 2016 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Jan. 26, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the BIO CEO & Investor Conference on Tuesday, February 9th, 2016 at 1:00 PM...
VBI Vaccines to Present at the Noble Financial Emerging Growth Investor Conference
18 janv. 2016 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Jan. 18, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the Noble Financial Emerging Growth Investor Conference on Monday, January...
VBI Vaccines to Present at the LD Micro Conference
25 nov. 2015 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Nov. 25, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") is scheduled to present at the Eighth Annual LD Micro Conference on Thursday, December 3rd, 2015 at 1:30 PM ET...
VBI Vaccines Presents Update and New Data Supporting its Glioblastoma Immunotherapy Program at the ESMO Symposium on Immuno-Oncology
20 nov. 2015 08h40 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Nov. 20, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) ("VBI") today presented an update and new data supporting its glioblastoma multiforme ("Glioblastoma" or "GBM")...
VBI Vaccines to Present Update and New Data Supporting its RSV and CMV Vaccine Programs at the World Vaccine Congress Europe
06 nov. 2015 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Nov. 6, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) ("VBI") is scheduled to present at the 16th Annual World Vaccine Congress Europe on Tuesday, November 10th, 2015 at...